“An Audit to Evaluate the Clinical Safety and PSA Response of Firmagon® (Degarelix) in Patients With Advanced Metastatic Prostate Cancer -”. Journal of Cancer Research Updates, vol. 2, no. 1, Jan. 2013, pp.  21-25, https://doi.org/10.6000/1929-2279.2013.02.01.4.